Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IconBSP:ICLR34 95 EV-to-OCF is 2.85 as of Sep. 04, 2026, which is 87% below its 10-year median of 21.80. GuruFocus rates BSP:ICLR34 with a GF Score™ of 95/100 and a GF Value™ of R$52.94. The stock has 5 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Icon ranks worse than 64.79% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Icon's Enterprise Value is R$16,283 Mil.
Icon's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was R$5,720 Mil. Therefore, Icon's EV-to-OCF for today is 2.85.
The historical rank and industry rank for Icon's EV-to-OCF or its related term are showing as below:
BSP:ICLR34'
s EV-to-OCF Range Over the Past 10 Years
Min: 9.75 Med: 21.8 Max: 48.48
Current: 14.21
During the past 13 years, the highest EV-to-OCF of Icon was 48.48. The lowest was 9.75. And the median was 21.80.
BSP:ICLR34's EV-to-OCF is ranked worse than 64.79% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 5.92
vs BSP:ICLR34: 14.21
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-09-04), Icon's stock price is R$41.72.
Icon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was R$2.777. Therefore, Icon's PE Ratio (TTM) for today is 15.02.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Icon's share price for today is R$41.72.
Icon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$2.777.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Icon EV-to-OCF Related Terms
Icon EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Icon's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:ICLR34 vs CRL, RVTY, MEDP: EV-to-OCF Comparison
For the Diagnostics & Research subindustry, Icon's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Icon EV-to-OCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Icon's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Icon's EV-to-OCF falls into.
Icon's current Enterprise Value is R$16,283 Mil.
Icon's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$5,720 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Icon (BSP:ICLR34) has a EV-to-OCF of 2.85 as of Sep. 04, 2026. This is 87% below median its historical median of 21.80. Over the past decade, Icon's EV-to-OCF has ranged from 9.75 to 48.48. According to the industry distribution chart, Icon ranks #138 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 64.8%.
Is Icon's EV-to-OCF too high?
Icon's current EV-to-OCF of 2.85 is 87% below median its 10-year median of 21.80. Over the past 10 years, this metric has ranged from a low of 9.75 to a high of 48.48. The Medical Diagnostics & Research industry median EV-to-OCF is 5.92. Icon's value of 2.85 is 51.9% below this industry median. Based on the distribution chart, Icon ranks #138 out of 213 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Icon has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Icon's EV-to-OCF compare to CRL and RVTY?
According to the Medical Diagnostics & Research industry distribution chart, Icon ranks #138 out of 213 companies for EV-to-OCF. This places Icon in the lower half of its industry. The industry median EV-to-OCF is 5.92. Icon's value of 2.85 is 51.9% below this benchmark. Historically, Icon's own EV-to-OCF has ranged from 9.75 to 48.48 over the past decade. While the company's 10-year median is 21.80 vs. the industry median of 5.92, Icon has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Diagnostics & Research company?
The median EV-to-OCF among Medical Diagnostics & Research companies is 5.92, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Icon's current EV-to-OCF of 2.85 is 51.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median EV-to-OCF is 5.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Icon's current EV-to-OCF is 2.85, which is 87% below median its own 10-year median of 21.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icon stock overvalued right now?
Icon (BSP:ICLR34) has a current EV-to-OCF of 2.85. The stock's GF Value™ is R$52.94, compared to a current price of R$41.72 — trading 21.2% below its estimated fair value. The current EV-to-OCF is 2.85, which is 87% below median its 10-year median of 21.80 and 51.9% below the Medical Diagnostics & Research industry median of 5.92. Icon's overall GF Score™ is 95/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Icon (BSP:ICLR34), the current EV-to-OCF is 2.85 as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Icon (BSP:ICLR34) Overvalued in 2026?
Based on GuruFocus' analysis, Icon stock appears to be undervalued.
The current stock price of R$41.72 is trading 21.2% below its estimated GF Value™ of R$52.94.
Key valuation signals for BSP:ICLR34:
EV-to-OCF: 2.85 (87% below median its 10-year median of 21.80)
GF Value™: R$52.94 vs. price of R$41.72 (21.2% below fair value)
Industry Position: 51.9% below the Medical Diagnostics & Research median (#138 of 213)
No single metric tells the full story. See the BSP:ICLR34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
95GF Score
Get the complete analysis for BSP:ICLR34
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:ICLR34 has been successfully added to your 
